Off-label transapical beating-heart transcatheter mitral valve replacement in severe mitral annular calcification.
Multimed Man Cardiothorac Surg
; 20222022 11 04.
Article
em En
| MEDLINE
| ID: mdl-36331192
ABSTRACT
The recent CE mark approval of a novel transapical transcatheter beating-heart replacement system, anchored by an apical pad, expanded the therapeutic options for patients with a significantly diseased mitral valve who are not eligible for conventional surgery. However, this self-expandable bioprosthesis is-despite promising data from the first European real-world experience-not approved for patients with severe mitral annular calcification. In this video tutorial, we provide a step-by-step description of an off-label transapical mitral valve replacement in a patient with severe degenerative mitral valve disease and limited alternative treatment options.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Calcinose
/
Próteses Valvulares Cardíacas
/
Implante de Prótese de Valva Cardíaca
/
Doenças das Valvas Cardíacas
/
Insuficiência da Valva Mitral
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article